505 related articles for article (PubMed ID: 29487874)
21. Epidemiological profile and risk factors of HIV and HBV/HCV co-infection in Fujian Province, southeastern China.
Wu S; Yan P; Yang T; Wang Z; Yan Y
J Med Virol; 2017 Mar; 89(3):443-449. PubMed ID: 27552721
[TBL] [Abstract][Full Text] [Related]
22. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.
Maida I; Ríos MJ; Pérez-Saleme L; Ramos B; Soriano V; Pegram PS; Mura MS; Sánchez-Margalet V; Saldívar-Cornejo I; Wilkin A; Babudieri S; Núñez M
AIDS Res Hum Retroviruses; 2008 May; 24(5):679-83. PubMed ID: 18462085
[TBL] [Abstract][Full Text] [Related]
23. Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan.
Ruzibakiev R; Kato H; Ueda R; Yuldasheva N; Hegay T; Avazova D; Kurbanov F; Zalalieva M; Tuichiev L; Achundjanov B; Mizokami M
Intervirology; 2001; 44(6):327-32. PubMed ID: 11805437
[TBL] [Abstract][Full Text] [Related]
24. Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa.
Barth RE; Huijgen Q; Tempelman HA; Mudrikova T; Wensing AM; Hoepelman AI
J Med Virol; 2011 Jun; 83(6):929-34. PubMed ID: 21503902
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya.
Muriuki BM; Gicheru MM; Wachira D; Nyamache AK; Khamadi SA
BMC Res Notes; 2013 Sep; 6():363. PubMed ID: 24016453
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B and C virus infection among HIV patients within the public and private healthcare systems in Chile: A cross-sectional serosurvey.
Weitzel T; Rodríguez F; Noriega LM; Marcotti A; Duran L; Palavecino C; Porte L; Aguilera X; Wolff M; Cortes CP
PLoS One; 2020; 15(1):e0227776. PubMed ID: 31917810
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of syphilis, HBV, and HCV co-infection, and low rate of effective vaccination against hepatitis B in HIV-infected patients in West China hospital.
Yang T; Chen Q; Li D; Wang T; Gou Y; Wei B; Tao C
J Med Virol; 2018 Jan; 90(1):101-108. PubMed ID: 28792076
[TBL] [Abstract][Full Text] [Related]
30. A Cross Section Study to Determine the Prevalence of Antibodies against HIV Infection among Hepatitis B and C Infected Individuals.
Flores GL; de Almeida AJ; Miguel JC; Cruz HM; Portilho MM; Scalioni Lde P; Marques VA; Lewis-Ximenez LL; Lampe E; Villar LM
Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26978383
[TBL] [Abstract][Full Text] [Related]
31. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.
Rouet F; Chaix ML; Inwoley A; Msellati P; Viho I; Combe P; Leroy V; Dabis F; Rouzioux C;
J Med Virol; 2004 Sep; 74(1):34-40. PubMed ID: 15258966
[TBL] [Abstract][Full Text] [Related]
32. Transfusion-transmissible infections among blood donors in Kathmandu, Nepal.
Shrestha AC; Ghimire P; Tiwari BR; Rajkarnikar M
J Infect Dev Ctries; 2009 Dec; 3(10):794-7. PubMed ID: 20009282
[TBL] [Abstract][Full Text] [Related]
33. Performance of rapid diagnostic tests for detection of Hepatitis B and C markers in HIV infected patients.
Barbosa JR; Colares JKB; Flores GL; Cortes VF; Miguel JC; Portilho MM; Marques VA; Potsch DV; Brandão-Mello CE; Amendola-Pires M; Pilotto JH; Lima DM; Lampe E; Villar LM
J Virol Methods; 2017 Oct; 248():244-249. PubMed ID: 28782578
[TBL] [Abstract][Full Text] [Related]
34. The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria.
Forbi JC; Gabadi S; Alabi R; Iperepolu HO; Pam CR; Entonu PE; Agwale SM
Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):535-7. PubMed ID: 17612776
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
Sagoe KW; Agyei AA; Ziga F; Lartey M; Adiku TK; Seshi M; Arens MQ; Mingle JA
J Med Virol; 2012 Jan; 84(1):6-10. PubMed ID: 22095533
[TBL] [Abstract][Full Text] [Related]
36. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ
World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038
[TBL] [Abstract][Full Text] [Related]
37. [Detected of associated contagious parameters of blood recipients before transfusion and their clinical significance].
Li ML; Liu XX; Sun AH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb; 27(1):54-6. PubMed ID: 23855132
[TBL] [Abstract][Full Text] [Related]
38. Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naïve individuals in Kumasi, Ghana.
Boateng R; Mutocheluh M; Dompreh A; Obiri-Yeboah D; Odame Anto E; Owusu M; Narkwa PW
PLoS One; 2019; 14(4):e0215377. PubMed ID: 31002687
[TBL] [Abstract][Full Text] [Related]
39. Serological markers and risk factors for hepatitis B and C viruses in patients infected with human immunodeficiency virus.
Hoyos-Orrego A; Massaro-Ceballos M; Ospina-Ospina M; Gómez-Builes C; Vanegas-Arroyave N; Tobón-Pereira J; Jaramillo-Hurtado J; Rugeles-López MT
Rev Inst Med Trop Sao Paulo; 2006; 48(6):321-6. PubMed ID: 17221128
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of HIV, HBV, HCV, and HTLV among Pregnant Women in Southwestern Nigeria.
Opaleye OO; Igboama MC; Ojo JA; Odewale G
J Immunoassay Immunochem; 2016; 37(1):29-42. PubMed ID: 25879258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
